Vaccine-Med's Factsheet • November 30, 2025
NOVEMBER
+1.07%
YEAR TO DATE
+1.22%
1 YEAR
+1.22%
5 YEARS
-49.36%
ANNUALIZED RETURN
-12.8%
TRACK RECORD
5.2 years
About Vaccine-Med
Vaccines have saved millions of lives for decades and protect against infectious diseases. With the recent Covid-19 pandemic, vaccine development became one of the hottest topics globally, as efforts to immunize the population from this virus turned into a priority for all.
Several infectious diseases have efficient prophylactic (preventive) vaccines available. In the future, new infections will appear, and new vaccines will have to be developed. The global vaccine market enjoys high entry barriers and benefits from substantial funding from government and humanitarian organisations for Research & Development.
Vaccine-Med Smart Portfolio allocates in stocks, based on eToro's asset universe, of vaccines manufacturers, among Pharmaceuticals and Biotechnology companies from all parts of the world, that have ongoing studies in several phases of existing and new vaccines for diseases that affect humans.
The minimum investment amount for this portfolio is $500.
Several infectious diseases have efficient prophylactic (preventive) vaccines available. In the future, new infections will appear, and new vaccines will have to be developed. The global vaccine market enjoys high entry barriers and benefits from substantial funding from government and humanitarian organisations for Research & Development.
Vaccine-Med Smart Portfolio allocates in stocks, based on eToro's asset universe, of vaccines manufacturers, among Pharmaceuticals and Biotechnology companies from all parts of the world, that have ongoing studies in several phases of existing and new vaccines for diseases that affect humans.
The minimum investment amount for this portfolio is $500.
Smart Portfolio Stats
Type
Smart Portfolio
Copiers
280
Assets Under Copy
$300K-$1M
Risk Score
5
Type
Smart Portfolio
Copiers
280
Assets Under Copy
$300K-$1M
Risk Score
5
Trades
No trades during this period.
Drawdowns
Worst Drawdowns
Depth | Start | End | Total months |
|---|---|---|---|
-72.47% | Sep 2021 | - | 51 |
-14.81% | Feb 2021 | Apr 2021 | 2 |
-13.8% | May 2021 | Aug 2021 | 3 |
-2.68% | Dec 2020 | Jan 2021 | 1 |
Performance Metrics
Score 2.4/10
Beta
1.04
1.04
0
0.8
1.2
0
2
Sharpe Ratio
-0.34
-0.34
-1
0.5
1
1.5
1.5
Sortino Ratio
-0.47
-0.47
-1
1
2
3
3
Jensen's Alpha
-22.29
-22.29
-23
0
2
4.5
4.5
Omega Ratio
0.53
0.53
0
1
1.5
2.5
2.5
Treynor Ratio
-0.91
-0.91
-1
0.75
1.25
2
2
Information Ratio
-0.82
-0.82
-1
0.3
0.6
1
1
Calmar Ratio
-0.18
-0.18
-1
0.3
0.6
1
1
Beta
1.04
1.04
0
0.8
1.2
0
2
Sharpe Ratio
-0.34
-0.34
-1
0.5
1
1.5
1.5
Sortino Ratio
-0.47
-0.47
-1
1
2
3
3
Jensen's Alpha
-22.29
-22.29
-23
0
2
4.5
4.5
Omega Ratio
0.53
0.53
0
1
1.5
2.5
2.5
Treynor Ratio
-0.91
-0.91
-1
0.75
1.25
2
2
Information Ratio
-0.82
-0.82
-1
0.3
0.6
1
1
Calmar Ratio
-0.18
-0.18
-1
0.3
0.6
1
1
Diversification
Sectors Breakdown
- Sector
- Total
- 🧬 Health Technology90.51%
- 🏥 Health Services7.7%
- 💵 Cash1.29%
Exchanges Breakdown
- Exchange
- Total
- 🇺🇸 Nasdaq57.2%
- 🇺🇸 NYSE28.55%
- 🇫🇷 Euronext Paris7.46%
- 🇩🇰 Copenhagen Stock Exchange5.01%
Countries Breakdown
- Country
- Total
- 🇺🇸 United States63.32%
- 🇫🇷 France11.75%
- 🇩🇪 Germany11.6%
- 🇬🇧 United Kingdom6.53%
- 🇩🇰 Denmark5.01%
Dividends
Dividend Yield
1.04%
6 out of 20 instruments pay dividend.
0 dividend payments in the next 30 days.
Highest Dividend: $PFE (6.65%)
Dividend Yield Breakdown
Instrument | Portfolio Yield | Company Yield | Per Share |
|---|---|---|---|
 PFE | 0.29% | 6.65% | $1.66 |
 MRK | 0.2% | 3.27% | $3.04 |
 JNJ | 0.2% | 2.43% | $4.81 |
 SNY | 0.14% | 3.28% | $1.48 |
 AZN | 0.11% | 1.71% | $1.42 |
 ABT | 0.1% | 1.88% | $2.16 |
Next Dividends
Stock | Type | Date | Pay Per Share |
|---|
Monthly Returns
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk. Past performance is not an indication of future results